NACDS supports Dextromethorphan Abuse Reduction Act of 2007

Steven Anderson, president/CEO of NACDS, applauded the Dextromethorphan Abuse Reduction Act of 2007, introduced by Sen. Joseph R. Biden Jr. (D, Del.). Anderson stated, "The abuse of dextromethorphan—especially by teenagers—is a serious concern, and our industry is committed to doing its part to combat this problem. This bill is a product of Sen. Biden's out-front leadership and dedication, and NACDS is pleased to play a role in the development of a legislative solution. We will continue working closely with Sen. Biden and his colleagues as the Dextromethorphan Abuse Reduction Act moves forward in Congress." Dextromethorphan is an ingredient in many cough and cold medications. The act prohibits the unregulated sale of the bulk form of dextromethorphan; prohibits the sale of dextromethorphan-containing products to buyers under 18 years old-a move already voluntarily taken by several major retail stores; and provides robust funding for prevention and educational programs to combat OTC and prescription drug abuse. The trade group for OTC makers—the Consumer Healthcare Products Association—also commended Sen. Biden for the legislation.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.